<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2079-5696</issn><issn publication-format="electronic">2079-5831</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">109264</article-id><article-id pub-id-type="doi">10.26442/20795696.2022.3.201683</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>BEST PRACTICE</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>В ПОМОЩЬ КЛИНИЦИСТУ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Relevance of abnormal uterine bleeding issue in young women and its comprehensive solution considering 2021 Russian Guidelines</article-title><trans-title-group xml:lang="ru"><trans-title>Актуальность проблемы аномальных маточных кровотечений у молодых женщин и ее комплексное решение в свете российских рекомендаций 2021</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9065-5689</contrib-id><name-alternatives><name xml:lang="en"><surname>Chernukha</surname><given-names>Galina E.</given-names></name><name xml:lang="ru"><surname>Чернуха</surname><given-names>Галина Евгеньевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof.</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф.</p></bio><email>g_chernukha@oparina4.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии им. акад. В.И. Кулакова» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-07-09" publication-format="electronic"><day>09</day><month>07</month><year>2022</year></pub-date><volume>24</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>198</fpage><lpage>205</lpage><history><date date-type="received" iso-8601-date="2022-07-09"><day>09</day><month>07</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-07-09"><day>09</day><month>07</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://gynecology.orscience.ru/2079-5831/article/view/109264">https://gynecology.orscience.ru/2079-5831/article/view/109264</self-uri><abstract xml:lang="en"><p>Abnormal uterine bleeding is a common problem in gynecology. It is a general term to describe menstrual disorders, including frequency, regularity, duration, and bleeding volume in non-pregnant women. Up to 1/3 of women experience this condition during their lifetime. Heavy menstrual bleeding not related to structural abnormality can be a serious health problem for many young women. It has a profound adverse impact on many aspects of their lives and increases the risk of iron deficiency anemia. However, up to half of these women consider the volume of menstrual blood loss normal, and physicians do not ask the relevant questions during counseling. The Russian Clinical Guidelines "Abnormal Uterine Bleeding" provide physicians guide to the assessment, management, and choice of treatment for women with heavy menstrual bleeding.</p></abstract><trans-abstract xml:lang="ru"><p>Аномальное маточное кровотечение – общий термин для описания нарушений менструального цикла, характеризующихся избыточной частотой, продолжительностью и/или объемом кровопотери у небеременных женщин. До 1/3 женщин испытывают это состояние в течение жизни. Обильные менструальные кровотечения, в основе которых нет структурной патологии, могут стать серьезной проблемой для многих молодых женщин, поскольку они оказывают глубокий негативный эффект на многие аспекты их жизни и повышают риск развития железодефицитной анемии. Однако до 1/2 таких женщин рассматривают объем менструальной кровопотери как нормальный, а врачи не задают необходимые вопросы во время консультирования. Российские клинические рекомендации «Аномальные маточные кровотечения» помогут врачам в диагностике и выборе лечения для женщин, страдающих от обильного менструального кровотечения. Гормональные методы лечения включают комбинированный оральный контрацептив эстрадиола валерат/диеногест и внутриматочную систему с левоноргестрелом.</p></trans-abstract><kwd-group xml:lang="en"><kwd>abnormal uterine bleeding</kwd><kwd>heavy menstrual bleeding</kwd><kwd>quality of life</kwd><kwd>menstrual blood loss</kwd><kwd>ferritin</kwd><kwd>iron deficiency anemia</kwd><kwd>levonorgestrel intrauterine system</kwd><kwd>combined oral contraceptive estradiol valerate/dienogest</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аномальное маточное кровотечение</kwd><kwd>обильное менструальное кровотечение</kwd><kwd>качество жизни</kwd><kwd>менструальная кровопотеря</kwd><kwd>ферритин</kwd><kwd>железодефицитная анемия</kwd><kwd>комбинированный оральный контрацептив эстрадиола валерат/диеногест</kwd><kwd>внутриматочная система с левоноргестрелом</kwd></kwd-group><funding-group><funding-statement xml:lang="en">This article is published with the support of Bayer.</funding-statement><funding-statement xml:lang="ru">Статья опубликована при поддержке компании «Байер».</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Munro MG, Critchley HOD, Frasere IS; FIGO Menstrual Disorders Working Group. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011;95(7):2204-8. DOI:10.1016/j.fertnstert.2011.03.079</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Fraser IS, Mansour D, Breymann C, et al. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int J Gynecol Obstet. 2015;128(3):196-200. DOI:10.1016/j.ijgo.2014.09.027</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. NICE guideline (NG88). Available at: https://www.nice.org.uk/guidance/NG88/ Accessed: 29.04.2022.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Bitzer J, Serrani M, Lahav A. Women’s attitudes towards heavy menstrual bleeding, and their impact on quality of life. Open Access J Contracept. 2013:4:21-8. DOI:10.2147/OAJC.S38993</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>da Silva Filho AL, Caetano C, Lahav A, et al. The difficult journey to treatment for women suffering from heavy menstrual bleeding: a multi-national survey. Eur J Contracept Reprod Health Care. 2021;26(5):390-8. DOI:10.1080/13625187.2021.1925881</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Mansour D, Hofmann A, Gemzell-Danielsson K. A Review of Clinical Guidelines on the Management of Iron Deficiency and Iron-Deficiency Anemia in Women with Heavy Menstrual Bleeding. Adv Ther. 2021;38(1):201-25. DOI:10.1007/s12325-020-01564-y</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Российское общество акушеров-гинекологов. Клинические рекомендации. Аномальные маточные кровотечения. 2021. Режим доступа: https://minzdrav.samregion.ru/wp-content/uploads/sites/28/2021/07/kr645.pdf/ Ссылка активна на 29.04.2022 [Rossiiskoe obshchestvo akusherov-ginekologov. Klinicheskie rekomendatsii. Anomal'nye matochnye krovotecheniia. 2021. Available at: https://minzdrav.samregion.ru/wp-content/uploads/sites/28/2021/07/kr645.pdf/ Accessed: 29.04.2022 (in Russian)].</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Singh S, Best C, Dunn S, et al. No. 292-Abnormal Uterine Bleeding in Pre-Menopausal Women. J Obstet Gynaecol Can. 2018;40(5):e391-415. DOI:10.1016/j.jogc.2018.03.007</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Munro MG. Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years. Best Pract Res Clin Obstet Gynaecol. 2017;40:3-22. DOI:10.1016/j.bpobgyn.2016.09.011</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Committee on Practice Bulletins–Gynecology. Practice bulletin no. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction. Obstet Gynecol. 2013;122(1):176-85. DOI:10.1097/01.AOG.0000431815.52679.bb</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393-408. DOI:10.1002/ijgo.12666</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Munro MG. Abnormal uterine bleeding: A well-travelled path to iron deficiency and anemia. Int J Gynecol Obstet. 2020;150:275-77. DOI:10.1002/ijgo.13180</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Percy L, Mansour D, Fraser I. Iron deficiency and iron deficiency anaemia in women. Best Pract Res Clin Obstet Gynaecol. 2017;40:55-67. DOI:10.1016/j.bpobgyn.2016.09.007</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387(10021):907-16. DOI:10.1016/S0140-6736(15)60865-0</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Mirza FG, Abdul-Kadir R, Breymann C, et al. Impact and management of iron deficiency and iron deficiency anemia in women’s health. Exp Rev Hematol. 2018;11(9):727-36. DOI:10.1080/17474086.2018.1502081</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Ших Е.В., Бриль Ю.А. Железодефицит: катастрофа для нейрогенеза. StatusPraesens: гинекология, акушерство, бесплодный брак. 2018;5(51):82-8 [Shikh EV, Bril' IuA. Zhelezodefitsit: katastrofa dlia neirogeneza. StatusPraesens: ginekologiia, akusherstvo, besplodnyi brak. 2018;5(51):82-8 (in Russian)].</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Виноградова М.А. Анемия у женщин репродуктивного возраста: диагностика и коррекция железодефицита. Акушерство и гинекология. 2019;6:140-5 [Vinogradova MA. Anemiia u zhenshchin reproduktivnogo vozrasta: diagnostika i korrektsiia zhelezodefitsita. Akusherstvo i ginekologiia. 2019;6:140-5 (in Russian)]. DOI:10.18565/aig.2019.6.140-145</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Moos T, Skjorringe T, Thomsen LL. Iron deficiency and iron treatment in the fetal developing brain – a pilot study introducing an experimental rat model. Reprod Health. 2018;15(Suppl. 1):93. DOI:10.1186/s12978-018-0537-0</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Kaveh M, Sadegi K, Salarzaei M, Parooei F. Comparison of diagnostic accuracy of saline infusion sonohysterography, transvaginal sonography, and hysteroscopy in evaluating the endometrial polyps in women with abnormal uterine bleeding: a systematic review and meta-analysis. Wideochir Inne Tech Maloinwazyjne. 2020;15(3):403-15. DOI:10.5114/wiitm.2020.93791</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Lunardi Rocha AL, Cristina França Ferreira M, Mara Lamaita R, et al. Heavy menstrual bleeding: a global survey of health care practitioners’ perceptions. Eur J Contracept Reprod Health Care. 2018;23(4):288-94. DOI:10.1080/13625187.2018.1483018</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Fraser IS, Parke S, Mellinger U, et al. Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care. 2011;16(4):258-69. DOI:10.3109/13625187.2011.591456</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Yu Q, Zhou Y, Suturina L, et al Efficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial. J Womens Health (Larchmt). 2018;27(10):1225-32. DOI:10.1089/jwh.2017.6522</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Доброхотова Ю.Э., Ибрагимова Д.М., Гришин И.И. Меноррагия: есть ли пути решения? Медицинский совет. 2016;12:12-3 [Dobrokhotova YE, Ibragimova DM, Grishin II. Menorrhagia: are there any solutions? Meditsinskii sovet. 2016;12:12-3 (in Russian)]. DOI:10.21518/2079-701X-2016-12-12-13</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Hickey M, Agarwal S. Unscheduled bleeding in combined oral contraceptive users: focus on extended-cycle and continuous-use regimens. J Fam Plann Reprod Health Care. 2009;35(4):245-8. DOI:10.1783/147118909789587411</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Dinger J, Möhner S, Heinemann K. Combined oral contraceptives containing dienogest and estradiol valerate may carry a lower risk of venous and arterial thromboembolism compared to conventional preparations: Results from the extended INAS-SCORE study. Front Womens Health. 2020;5:1-8. DOI:10.15761/FWH.1000178</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Chen BA, Eisenberg DL, Schreiber CA, et al. Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding. Am J Obstet Gynecol. 2020;222(4S):S888.e1-6. DOI:10.1016/j.ajog.2019.11.1288</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Gupta J, Kai J, Middleton L, et al. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med. 2013;368:128-37. DOI:10.1056/NEJMoa1204724</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Lethaby A, Hussain M, Rishworth JR, Rees MC. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2015;4:CD002126. DOI:10.1002/14651858.CD002126.pub3</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Beelen P, van den Brink MJ, Herman MC, et al. Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding. Am J Obstet Gynecol. 2021;224(2):187.e1-10. DOI:10.1016/j.ajog.2020.08.016</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>van den Brink MJ, Beelen P, Herman MC, et al. The levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding: a cost-effectiveness analysis. BJOG. 2021;128(12):2003-11. DOI:10.1111/1471-0528.16836</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Драпкина О.М., Мартынов А.И., Байда А.П., и др. Резолюция экспертного совета «Актуальные вопросы железодефицита в Российской Федерации». Кардиоваскулярная терапия и профилактика. 2020;19(5):2700 [Drapkina OM, Martynov AI, Baida AP. Resolution of the expert council “Relevant issues of iron deficiency in the Russian Federation”. Cardiovascular Therapy and Prevention. 2020;19(5):2700 (in Russian)]. DOI:10.15829/1728-8800-2020-2700</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Friedman AJ, Shander A, Martin SR, et al. Iron deficiency anemia in women: a practical guide to detection, diagnosis, and treatment. Obstet Gynecol Surv. 2015;70:342-53. DOI:10.1097/OGX.0000000000000172</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>DeLoughery TG. Iron deficiency anemia. Med Clin North Am. 2017;101(2):319-32. DOI:10.1016/j.mcna.2016.09.004</mixed-citation></ref></ref-list></back></article>
